Circulating microRNAs as potential biomarkers for smoking-related interstitial fibrosis

References

• Aldonyte R, Eriksson S, Piitulainen E, Wallmark A, Janciauskiene S. (2004). Analysis of systemic biomarkers in COPD patients. COPD 1:155–164.
   PubMedGoogle Scholar
• American Thoracic Society. (2000). Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161:646–664.
   PubMed Web of Science ®Google Scholar
• Bakhru A, Erlinger TP. (2005). Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2:e160.
   PubMed Web of Science ®Google Scholar
• Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297.
   PubMed Web of Science ®Google Scholar
• Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. (2002). Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22:1668–1673.
   PubMed Web of Science ®Google Scholar
• Bruno A, Alessi M, Soresi S, Bonanno A, Riccobono L, Montalbano AM, Albano GD, Gjomarkaj M, Profita M. (2011). Increased leptin/leptin receptor pathway affects systemic and airway inflammation in COPD former smokers. J Inflamm Res 4:51–59.
   Google Scholar
• Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997–1006.
   PubMed Web of Science ®Google Scholar
• Cowan ML, Vera J. (2008). Proteomics: advances in biomarker discovery. Expert Rev Proteomics 5:21–23.
   PubMedGoogle Scholar
• Davalos V, Esteller M. (2010). MicroRNAs and cancer epigenetics: a macrorevolution. Curr Opin Oncol 22:35–45.
   PubMed Web of Science ®Google Scholar
• Huang YC, Dai Y, Zhang J, Cheng J, Lu Y, Li D, Wang C, Ma K, Xue F, Tan L, Qin B. (2012). Circulating miRNAs might be promising biomarkers to reflect the dynamic changes of smoking-related interstitial fibrosis. Environmental Toxicology.
   Google Scholar
• Huang Y, Yang S, Zhang J, Tan L, Jiang F, Li N, Cheng J, Lu Y, Dai Y. (2010). MicroRNAs as promising biomarkers for diagnosing human cancer. Cancer Invest 28:670–671.
   PubMed Web of Science ®Google Scholar
• Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. (2009). Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55:1944–1949.
   PubMed Web of Science ®Google Scholar
• Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. (2010). Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 41:316–325.
   PubMed Web of Science ®Google Scholar
• Khan AP, Poisson LM, Bhat VB, Fermin D, Zhao R, Kalyana-Sundaram S, Michailidis G, Nesvizhskii AI, Omenn GS, Chinnaiyan AM, Sreekumar A. (2010). Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer. Mol Cell Proteomics 9:298–312.
   PubMed Web of Science ®Google Scholar
• King VL, Hatch NW, Chan HW, de Beer MC, de Beer FC, Tannock LR. (2010). A murine model of obesity with accelerated atherosclerosis. Obesity (Silver Spring) 18:35–41.
   PubMed Web of Science ®Google Scholar
• Koczulla AR, Noeske S, Herr C, Jörres RA, Römmelt H, Vogelmeier C, Bals R. (2010). Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers. Respiration 79:61–67.
   Google Scholar
• Leitch DN, Harkawat R, Askew J, Masel P, Hendrick DJ. (2005). Relation of expired carbon monoxide to smoking history, lapsed time, TLCO measurement and passive smoking. Respir Med 99:32–38.
   Google Scholar
• Liang Y, Ridzon D, Wong L, Chen C. (2007). Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8:166.
   PubMed Web of Science ®Google Scholar
• Marques-Vidal P, Bochud M, Bastardot F, Lüscher T, Ferrero F, Gaspoz JM, Paccaud F, Urwyler A, von Känel R, Hock C, Waeber G, Preisig M, Vollenweider P. (2011). Levels and determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus study). PLoS ONE 6:e21002.
   Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513–10518.
   PubMed Web of Science ®Google Scholar
• Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. (2007). Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 176:277–284.
   PubMed Web of Science ®Google Scholar
• Peikert T, Daniels CE, Beebe TJ, Meyer KC, Ryu JH; Interstitial Lung Diseases Network of the American College of Chest Physicians. (2008). Assessment of current practice in the diagnosis and therapy of idiopathic pulmonary fibrosis. Respir Med 102:1342–1348.
   PubMed Web of Science ®Google Scholar
• Ruvkun G. (2008). The perfect storm of tiny RNAs. Nat Med 14:1041–1045.
   PubMed Web of Science ®Google Scholar
• Tang X, Gal J, Zhuang X, Wang W, Zhu H, Tang G. (2007). A simple array platform for microRNA analysis and its application in mouse tissues. RNA 13:1803–1822.
   PubMed Web of Science ®Google Scholar
• Tang G, Tang X, Mendu V, Tang X, Jia X, Chen QJ, He L. (2008). The art of microRNA: various strategies leading to gene silencing via an ancient pathway. Biochim Biophys Acta 1779:655–662.
   PubMedGoogle Scholar
• van der Vaart H, Postma DS, Timens W, Hylkema MN, Willemse BW, Boezen HM, Vonk JM, de Reus DM, Kauffman HF, ten Hacken NH. (2005). Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir Res 6:22.
   PubMed Web of Science ®Google Scholar
• van der Vaart H, Postma DS, Timens W, ten Hacken NH. (2004). Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59:713–721.
   PubMed Web of Science ®Google Scholar
• Waldman SA, Terzic A. (2008). MicroRNA signatures as diagnostic and therapeutic targets. Clin Chem 54:943–944.
   PubMedGoogle Scholar
• Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ. (2009). Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106:4402–4407.
   PubMed Web of Science ®Google Scholar
• Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, Ju J. (2007). Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 13:1668–1674.
   PubMed Web of Science ®Google Scholar
• Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, Alattar M, Deepak J, Stass SA, Jiang F. (2010). Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 67:170–176.
   PubMed Web of Science ®Google Scholar